Acted as Cayman Islands counsel to Dingdang Health Technology Group Ltd. (the "Issuer") in relation to its initial public offering of 33,537,000 shares and its listing on the Hong Kong Stock Exchange. The Issuer is a service provider in the digital retail pharmacy industry in China and ranked No. 3 in such industry by revenue in 2021. It is also the largest product and service provider in the on-demand digital pharmacy industry in China by revenue in 2021. The offering, which closed on 14 September 2022, raised approximately HK$402.0 million. The Maples team comprised partner Juno Huang, legal managers Melody Ching and Charmaine Chow. The Issuer was also advised by Clifford Chance as to Hong Kong and U.S. laws. The joint sponsors, China International Capital Corporation Hong Kong Securities Limited and CMB International Capital Limited, and the underwriters were advised by Paul Hastings as to Hong Kong and U.S. laws.
为叮当健康科技集团有限公司（简称"发行人"）就其首次公开招股发行33,537,000股股份及于香港交易所上市项目担任开曼群岛法律顾问。发行人是中国数字零售药房行业的服务提供商，按2021年收入计，发行人在该行业中排名第三。按2021年收入计，发行人也是中国即时到家数字药房行业最大的产品及服务提供商。此项目已于2022年9月14日完成，集资约4.02亿港元。Maples负责此次项目的团队成员包括合伙人Juno Huang黄子容，以及法务经理Melody Ching 程名之及Charmaine Chow周恩咏。高伟绅律师行担任发行人的香港和美国法律顾问。普衡律师事务所担任联席保荐人（中国国际金融香港证券有限公司及招银国际融资有限公司）和包销商的香港和美国法律顾问。
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.